Alimera Sciences, Inc.
$2.0M 3,868 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Grifols USA, LLC
Grifols USA, LLC reported $1,959,878.95 across General Payments, Research, and Ownership to 23,281 physicians and teaching hospitals across 23,281 transactions.
- $2.0M
- All-tracks total
- 23,281
- Transactions
- 23,281
- Recipients
- +$85.7K
- General Payments vs PY2023
Grifols USA, LLC reported $1,959,878.95 across all CMS Open Payments tracks (General + Research + Ownership) to 23,281 physicians and teaching hospitals in Program Year 2024 - ranking #451 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,959,878.95, averaging $84.18 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer grifols-usa-llc Grifols USA, LLC
$2.0M · #451/1,925 · 0.0% industry · PY2024
- TOT $2.0M
- RANK #451
- SHARE 0.0%
- TXN 23,281
- RCP 23,281
- CAT 6
- GEN $2.0M
- ΔGEN +$85.7K
- TOP1 3.5%
- PY 2024
Volume peers
Nearest volume peer: Alimera Sciences, Inc. ($2.0M)
Grifols USA, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Grifols USA, LLC's CMS-reported General Payments increased by $85.7K (+4.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: GRIFOLS USA, LLCPY2023: GRIFOLS USA, LLCPY2024: Grifols USA, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,874,204.06
- PY2024
- $1,959,878.95
What the Data Shows for Grifols USA, LLC
Grifols USA, LLC ranks #451 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $1,959,878.95 across 23,281 transactions to 23,281 physicians and teaching hospitals - $84.18 per transaction and $84.18 per recipient on average.
Of the 6 general-payment categories charted below, "Compensation for Services Other Than Consulting" is the largest at $723.0K across 282 transactions, 36.9% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 6 types of general payments, Grifols USA, LLC's largest category was "Compensation for Services Other Than Consulting" at $723.0K - 36.9% of General Payments.
Grifols USA, LLC reports 6 general-payment categories - the top three are Compensation for Services Other Than Consulting (36.9%), Food and Beverage (29.7%), and Consulting Fee (15.0%). The remaining 3 categories make up 18.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Grifols USA, LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $723.0K | 282 | 36.9% |
| Food and Beverage | $582.1K | 22,212 | 29.7% |
| Consulting Fee | $294.1K | 83 | 15.0% |
| Travel and Lodging | $202.8K | 671 | 10.3% |
| Education | $80.5K | 20 | 4.1% |
| Honoraria | $77.4K | 13 | 4.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $309,057.34 (15.8%) of $1,959,878.95 in this company's General Payments records across 9,114 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Grifols USA, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Antoine Azar
$68,870.85 across 95 reported transactions
- 2
Stephen Scholand
$63,602.89 across 81 reported transactions
- 3
Suraj Muley
$60,213.97 across 74 reported transactions
- 4
Fredrick Melik-Abrahamian
$58,248.83 across 71 reported transactions
- 5
Gil Wolfe
$58,120.80 across 77 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Grifols USA, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Grifols USA, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Grifols USA, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
PolyNovo North America LLC
$2.0M 5,925 recipients
Compare payment profiles
Ferring Pharmaceuticals Inc.
$2.0M 21,199 recipients
Compare payment profiles
CooperSurgical, Inc.
$1.9M 9,542 recipients
Compare payment profiles
PROCEPT BioRobotics Corporation
$1.9M 8,013 recipients
Compare payment profiles
Biohaven Pharmaceutical Holding Company Ltd.
$2.0M 0 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.